The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells

Experimental Cell Research

Volumn 303, Issue 2, 2005, Pages 321-330

  Behren, Andreas ^a   Binder, Konrad ^a   Vucelic, Goran ^a   Herberhold, Stephan ^a   Hirt, Bernhard ^a   Loewenheim, Hubert ^a   Preyer, Serena ^a   Zenner, Hans Peter ^a   Simon, Christian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Invasion; NIH3T3; p38; ras; u PA

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PLASMINOGEN ACTIVATOR; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL INVASION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 12344260906     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.10.004     Document Type: Article

References (38)

1. R. Hernandez-Alcoceba, L. del Peso, and J.C. Lacal The Ras family of GTPases in cancer cell invasion Cell Mol. Life Sci. 57 2000 65 76
2. C.J. Marshall Ras effectors Curr. Opin. Cell Biol. 8 1996 197 204
3. D.T. Denhardt Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling Biochem. J. 318 Pt 3 1996 729 747
4. Y. Shi, and M. Gaestel In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance Biol. Chem. 383 2002 1519 1536
5. G. Chen, M. Hitomi, J. Han, and D.W. Stacey The p38 pathway provides negative feedback for Ras proliferative signaling J. Biol. Chem. 275 2000 38973 38980
6. D.W. Stacey, and H.F. Kung Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein Nature 310 1984 508 511
7. J. Downward Targeting RAS signalling pathways in cancer therapy Nat. Rev., Cancer 3 2003 11 22
8. M.O. Bradley, A.R. Kraynak, R.D. Storer, and J.B. Gibbs Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes Proc. Natl. Acad. Sci. U. S. A. 83 1986 5277 5281
9. J.Y. Zhang, and R.M. Schultz Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation Cancer Res. 52 1992 6682 6689
10. M. Janulis, S. Silberman, A. Ambegaokar, J.S. Gutkind, and R.M. Schultz Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts J. Biol. Chem. 274 1999 801 813
11. S. Huang, L. New, Z. Pan, J. Han, and G.R. Nemerow Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity J. Biol. Chem. 275 2000 12266 12272
12. Q. Han, J. Leng, D. Bian, C. Mahanivong, K.A. Carpenter, Z.K. Pan, J. Han, and S. Huang Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells J. Biol. Chem. 277 2002 48379 48385
13. M.S. Kim, E.J. Lee, H.R. Kim, and A. Moon p38 Kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells Cancer Res. 63 2003 5454 5461
14. Z. Li, Y. Jiang, R.J. Ulevitch, and J. Han The primary structure of p38g: a new member of p38 group of MAP kinases Biochem. Biophys. Res. Commun. 228 1996 334 340
15. X. Wang, C.H. McGowan, M. Zhao, L. He, J.S. Downey, C. Fearns, Y. Wang, S. Huang, and J. Han Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest Mol. Cell. Biol. 20 2000 4543 4552
16. G.L. Nicolson, G.E. Gallick, K.M. Dulski, W.H. Spohn, T.M. Lembo, and M.A. Tainsky Lack of correlation between intercellular junctional communication, p21rasEJ expression, and spontaneous metastatic properties of rat mammary cells after transfection with c-H-rasEJ or neo genes Oncogene 5 1990 747 753
17. C. Nerlov, D. De Cesare, F. Pergola, A. Caracciolo, F. Blasi, M. Johnsen, and P. Verde A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells EMBO J. 11 1992 4573 4582
18. W.A. Wybranietz, F. Prinz, M. Spiegel, A. Schenk, M. Bitzer, M. Gregor, and U.M. Lauer Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines J. Gene Med. 1 1999 265 274
19. G. Sweeney, R. Somwar, T. Ramlal, A. Volchuk, A. Ueyama, and A. Klip An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes J. Biol. Chem. 274 1999 10071 10078
20. Z. Wang, B.J. Canagarajah, J.C. Boehm, S. Kassisa, M.H. Cobb, P.R. Young, S. Abdel-Meguid, J.L. Adams, and E.J. Goldsmith Structural basis of inhibitor selectivity in MAP kinases Structure 6 1998 1117 1128
21. J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, D. Green, D. McNulty, M.J. Blumenthal, J.R. Heys, and S.W. Landvatter A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739 746
22. J. Lisnock, A. Tebben, B. Frantz, E.A. O'Neill, G. Croft, S.J. O'Keefe, B. Li, C. Hacker, S. de Laszlo, A. Smith, B. Libby, N. Liverton, J. Hermes, and P. LoGrasso Molecular basis for p38 protein kinase inhibitor specificity Biochemistry 37 1998 16573 16581
23. R. Pramanik, X. Qi, S. Borowicz, D. Choubey, R.M. Schultz, J. Han, and G. Chen p38 Isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity J. Biol. Chem. 278 2003 4831 4839
24. S. Ried, C. Jager, M. Jeffers, G.F. Vande Woude, H. Graeff, M. Schmitt, and E. Lengyel Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor J. Biol. Chem. 274 1999 16377 16386
25. E. Lengye, B. Singh, R. Gum, C. Nerlov, A. Sabichi, M. Birrer, and D. Boyd Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene Oncogene 11 1995 2639 2648
26. F. Miralles, M. Parra, C. Caelles, Y. Nagamine, J. Felez, and P. Munoz-Canoves UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element Mol. Cell. Biol. 18 1998 4537 4547
27. C. Zhang, R.A. Baumgartner, K. Yamada, and M.A. Beaven Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases J. Biol. Chem. 272 1997 13397 13402
28. X. Wang, C.H. McGowan, M. Zhao, L. He, J.S. Downey, C. Fearns, Y. Wang, S. Huang, and J. Han Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest Mol. Cell. Biol. 13 2000 (Jul. 20) 4543 4552
29. E. Martin-Blanco p38 MAPK signalling cascades: ancient roles and new functions Bioessays 22 2000 637 645
30. M. Zayzafoon, S. Botolin, and L.R. McCabe p38 And activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose J. Biol. Chem. 277 2002 37212 37218
31. G. Cirillo, L. Casalino, D. Vallone, A. Caracciolo, D. De Cesare, and P. Verde Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate Mol. Cell. Biol. 19 1999 6240 6252
32. F.J. Esteva, A.A. Sahin, T.L. Smith, Y. Yang, L. Pusztai, R. Nahta, T.A. Buchholz, A.U. Buzdar, G.N. Hortobagyi, and S.S. Bacus Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma Cancer 100 2004 499 506
33. R. Haq, J.D. Brenton, M. Takahashi, D. Finan, A. Finkielsztein, S. Damaraju, R. Rottapel, and B. Zanke Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence Cancer Res. 62 2002 5076 5082
34. Q. Deng, R. Liao, B.L. Wu, and P. Sun High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts J. Biol. Chem. 279 2004 1050 1059
35. D.V. Bulavin, O. Kovalsky, M.C. Hollander, and A.J. Fornace Jr. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a Mol. Cell Biol. 23 2003 3859 3871
36. W. Wang, J.X. Chen, R. Liao, Q. Deng, J.J. Zhou, S. Huang, and P. Sun Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence Mol. Cell. Biol. 22 2002 3389 3403
37. C. Simon, M.J. Hicks, A.J. Nemechek, R. Mehta, B.W. O'Malley Jr., H. Goepfert, C.M. Flaitz, and D. Boyd PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma Br. J Cancer 80 1999 1412 1419
38. M.S. Qui, and S.H. Green PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity Neuron 9 1992 705 717